The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice

Emily Suskin, Laura Hercher, Kathleen Erskine Aaron, Komal Bajaj

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Since its introduction four years ago, noninvasive prenatal screening for fetal aneuploidy (NIPS) has been widely adopted as a screening tool for women at a high risk for fetal aneuploidy. As use expands into the general population, questions arise concerning the integration of NIPS into preexisting screening paradigms. This study aims to examine the use of NIPS in current practice among prenatal counselors, predominantly in the United States, in order to inform strategies for the optimal use of both new and existing screening techniques. We electronically surveyed 208 members of the National Society of Genetic Counselors to ascertain how NIPS is currently being used. Genetic counselors were also queried as to the advantages and disadvantages of offering NIPS to all patients regardless of a priori risk. Results indicate substantial variation in practice regarding which patients are offered NIPS and how counselors have incorporated this technology into existing screening routines. The majority of participants report offering NIPS in conjunction with another method of screening for fetal aneuploidy, indicating that NIPS is being used as an addition rather than as a replacement. These screening methods primarily include nuchal translucency (NT) (45.1 %, n = 78) and first trimester serum screening, with or without an NT (19.7 %, n = 34). Furthermore, the majority report that they would be concerned about losing the clinical value of an NT in a complete transition to NIPS (85.4 %, n = 164). Counselors are evenly split on the merits of expanding the use of NIPS to the general population (con: 55.3 %, n = 105; pro: 44.7 %, n = 85). The lack of consensus suggests that updated practice guidelines might benefit counselors. In addition, respondents emphasized the need to better educate patients and providers about the risks, benefits, and limitations of the test.

Original languageEnglish (US)
Pages (from-to)1032-1043
Number of pages12
JournalJournal of Genetic Counseling
Volume25
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Genetic Counseling
Prenatal Diagnosis
Nuchal Translucency Measurement
Aneuploidy
Surveys and Questionnaires
N-(4-isothiocyanatophenethyl)spiperone
First Pregnancy Trimester
Practice Guidelines
Population
Counselors
Technology

Keywords

  • Aneuploidy
  • Cell-free DNA
  • Genetic counseling
  • Non-invasive prenatal testing
  • Noninvasive prenatal screening
  • Prenatal screening

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

@article{685fe72f5c044c7685c9c863c3316984,
title = "The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm: a Survey of Current Genetic Counseling Practice",
abstract = "Since its introduction four years ago, noninvasive prenatal screening for fetal aneuploidy (NIPS) has been widely adopted as a screening tool for women at a high risk for fetal aneuploidy. As use expands into the general population, questions arise concerning the integration of NIPS into preexisting screening paradigms. This study aims to examine the use of NIPS in current practice among prenatal counselors, predominantly in the United States, in order to inform strategies for the optimal use of both new and existing screening techniques. We electronically surveyed 208 members of the National Society of Genetic Counselors to ascertain how NIPS is currently being used. Genetic counselors were also queried as to the advantages and disadvantages of offering NIPS to all patients regardless of a priori risk. Results indicate substantial variation in practice regarding which patients are offered NIPS and how counselors have incorporated this technology into existing screening routines. The majority of participants report offering NIPS in conjunction with another method of screening for fetal aneuploidy, indicating that NIPS is being used as an addition rather than as a replacement. These screening methods primarily include nuchal translucency (NT) (45.1 {\%}, n = 78) and first trimester serum screening, with or without an NT (19.7 {\%}, n = 34). Furthermore, the majority report that they would be concerned about losing the clinical value of an NT in a complete transition to NIPS (85.4 {\%}, n = 164). Counselors are evenly split on the merits of expanding the use of NIPS to the general population (con: 55.3 {\%}, n = 105; pro: 44.7 {\%}, n = 85). The lack of consensus suggests that updated practice guidelines might benefit counselors. In addition, respondents emphasized the need to better educate patients and providers about the risks, benefits, and limitations of the test.",
keywords = "Aneuploidy, Cell-free DNA, Genetic counseling, Non-invasive prenatal testing, Noninvasive prenatal screening, Prenatal screening",
author = "Emily Suskin and Laura Hercher and Aaron, {Kathleen Erskine} and Komal Bajaj",
year = "2016",
month = "10",
day = "1",
doi = "10.1007/s10897-016-9934-0",
language = "English (US)",
volume = "25",
pages = "1032--1043",
journal = "Journal of Genetic Counseling",
issn = "1059-7700",
publisher = "Kluwer Academic/Human Sciences Press Inc.",
number = "5",

}

TY - JOUR

T1 - The Integration of Noninvasive Prenatal Screening into the Existing Prenatal Paradigm

T2 - a Survey of Current Genetic Counseling Practice

AU - Suskin, Emily

AU - Hercher, Laura

AU - Aaron, Kathleen Erskine

AU - Bajaj, Komal

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Since its introduction four years ago, noninvasive prenatal screening for fetal aneuploidy (NIPS) has been widely adopted as a screening tool for women at a high risk for fetal aneuploidy. As use expands into the general population, questions arise concerning the integration of NIPS into preexisting screening paradigms. This study aims to examine the use of NIPS in current practice among prenatal counselors, predominantly in the United States, in order to inform strategies for the optimal use of both new and existing screening techniques. We electronically surveyed 208 members of the National Society of Genetic Counselors to ascertain how NIPS is currently being used. Genetic counselors were also queried as to the advantages and disadvantages of offering NIPS to all patients regardless of a priori risk. Results indicate substantial variation in practice regarding which patients are offered NIPS and how counselors have incorporated this technology into existing screening routines. The majority of participants report offering NIPS in conjunction with another method of screening for fetal aneuploidy, indicating that NIPS is being used as an addition rather than as a replacement. These screening methods primarily include nuchal translucency (NT) (45.1 %, n = 78) and first trimester serum screening, with or without an NT (19.7 %, n = 34). Furthermore, the majority report that they would be concerned about losing the clinical value of an NT in a complete transition to NIPS (85.4 %, n = 164). Counselors are evenly split on the merits of expanding the use of NIPS to the general population (con: 55.3 %, n = 105; pro: 44.7 %, n = 85). The lack of consensus suggests that updated practice guidelines might benefit counselors. In addition, respondents emphasized the need to better educate patients and providers about the risks, benefits, and limitations of the test.

AB - Since its introduction four years ago, noninvasive prenatal screening for fetal aneuploidy (NIPS) has been widely adopted as a screening tool for women at a high risk for fetal aneuploidy. As use expands into the general population, questions arise concerning the integration of NIPS into preexisting screening paradigms. This study aims to examine the use of NIPS in current practice among prenatal counselors, predominantly in the United States, in order to inform strategies for the optimal use of both new and existing screening techniques. We electronically surveyed 208 members of the National Society of Genetic Counselors to ascertain how NIPS is currently being used. Genetic counselors were also queried as to the advantages and disadvantages of offering NIPS to all patients regardless of a priori risk. Results indicate substantial variation in practice regarding which patients are offered NIPS and how counselors have incorporated this technology into existing screening routines. The majority of participants report offering NIPS in conjunction with another method of screening for fetal aneuploidy, indicating that NIPS is being used as an addition rather than as a replacement. These screening methods primarily include nuchal translucency (NT) (45.1 %, n = 78) and first trimester serum screening, with or without an NT (19.7 %, n = 34). Furthermore, the majority report that they would be concerned about losing the clinical value of an NT in a complete transition to NIPS (85.4 %, n = 164). Counselors are evenly split on the merits of expanding the use of NIPS to the general population (con: 55.3 %, n = 105; pro: 44.7 %, n = 85). The lack of consensus suggests that updated practice guidelines might benefit counselors. In addition, respondents emphasized the need to better educate patients and providers about the risks, benefits, and limitations of the test.

KW - Aneuploidy

KW - Cell-free DNA

KW - Genetic counseling

KW - Non-invasive prenatal testing

KW - Noninvasive prenatal screening

KW - Prenatal screening

UR - http://www.scopus.com/inward/record.url?scp=84958255394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958255394&partnerID=8YFLogxK

U2 - 10.1007/s10897-016-9934-0

DO - 10.1007/s10897-016-9934-0

M3 - Article

C2 - 26879922

AN - SCOPUS:84958255394

VL - 25

SP - 1032

EP - 1043

JO - Journal of Genetic Counseling

JF - Journal of Genetic Counseling

SN - 1059-7700

IS - 5

ER -